General Biologicals Corporation (TPEX:4117)

General Biologicals Statistics

Total Valuation

TPEX:4117 has a market cap or net worth of TWD 252.42 million. The enterprise value is 2.57 billion.

Market Cap	252.42M
Enterprise Value	2.57B

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4117 has 60.83 million shares outstanding. The number of shares has increased by 4.63% in one year.

Current Share Class	60.83M
Shares Outstanding	60.83M
Shares Change (YoY)	+4.63%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.45%
Owned by Institutions (%)	1.64%
Float	35.25M

Valuation Ratios

The trailing PE ratio is 0.56.

PE Ratio	0.56
Forward PE	n/a
PS Ratio	1.17
PB Ratio	0.29
P/TBV Ratio	0.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	5.52
EV / Sales	11.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.50

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 2.79.

Current Ratio	2.00
Quick Ratio	1.78
Debt / Equity	2.79
Debt / EBITDA	n/a
Debt / FCF	-8.06
Interest Coverage	-11.11

Financial Efficiency

Return on equity (ROE) is 80.22% and return on invested capital (ROIC) is -7.53%.

Return on Equity (ROE)	80.22%
Return on Assets (ROA)	-3.31%
Return on Invested Capital (ROIC)	-7.53%
Return on Capital Employed (ROCE)	-4.90%
Weighted Average Cost of Capital (WACC)	1.54%
Revenue Per Employee	2.66M
Profits Per Employee	5.75M
Employee Count	81
Asset Turnover	0.05
Inventory Turnover	2.69

Taxes

In the past 12 months, TPEX:4117 has paid 40.67 million in taxes.

Income Tax	40.67M
Effective Tax Rate	8.05%

Stock Price Statistics

The stock price has decreased by -78.04% in the last 52 weeks. The beta is 0.91, so TPEX:4117's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-78.04%
50-Day Moving Average	11.80
200-Day Moving Average	14.95
Relative Strength Index (RSI)	10.41
Average Volume (20 Days)	842,050

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4117 had revenue of TWD 215.74 million and earned 465.84 million in profits. Earnings per share was 7.44.

Revenue	215.74M
Gross Profit	59.62M
Operating Income	-219.11M
Pretax Income	505.51M
Net Income	465.84M
EBITDA	-140.04M
EBIT	-219.11M
Earnings Per Share (EPS)	7.44

Balance Sheet

The company has 634.75 million in cash and 2.44 billion in debt, with a net cash position of -1.80 billion or -29.64 per share.

Cash & Cash Equivalents	634.75M
Total Debt	2.44B
Net Cash	-1.80B
Net Cash Per Share	-29.64
Equity (Book Value)	872.47M
Book Value Per Share	13.38
Working Capital	395.62M

Cash Flow

In the last 12 months, operating cash flow was -127.26 million and capital expenditures -175.10 million, giving a free cash flow of -302.36 million.

Operating Cash Flow	-127.26M
Capital Expenditures	-175.10M
Depreciation & Amortization	79.07M
Net Borrowing	168.11M
Free Cash Flow	-302.36M
FCF Per Share	-4.97

Margins

Gross margin is 27.63%, with operating and profit margins of -101.56% and 215.93%.

Gross Margin	27.63%
Operating Margin	-101.56%
Pretax Margin	234.31%
Profit Margin	215.93%
EBITDA Margin	-64.91%
EBIT Margin	-101.56%
FCF Margin	n/a

Dividends & Yields

TPEX:4117 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.63%
Shareholder Yield	-4.63%
Earnings Yield	184.55%
FCF Yield	-119.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4